Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion model by blocking NF-κB pathways. [electronic resource]
Producer: 20180723Description: 1189-1200 p. digitalISSN:- 1432-1912
- Amidohydrolases -- antagonists & inhibitors
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Benzamides -- pharmacology
- Benzoxazines -- pharmacology
- Cannabinoid Receptor Agonists -- pharmacology
- Carbamates -- pharmacology
- Cerebrovascular Disorders -- drug therapy
- Endocannabinoids -- physiology
- Hippocampus -- drug effects
- Macrophage Activation -- drug effects
- Male
- Morpholines -- pharmacology
- NF-kappa B -- antagonists & inhibitors
- Naphthalenes -- pharmacology
- Neuritis -- drug therapy
- Prefrontal Cortex -- drug effects
- Rats
- Rats, Sprague-Dawley
- Signal Transduction -- drug effects
- Transcription Factor RelA -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.